delivery type mark
সারা বাংলাদেশ থেকে অর্ডার করা যাবে।

D-4000040,000IU

Tablet
The Ibn Sina Pharmaceutical Ind. Ltd.
Generic: Cholecalciferol (Vit. D3)
recently bought1307 people recently viewed this.
Best Price
315.00
MRP
350.00
10% OFF

Additional Offers

Show all
Cashback ৳100 : For purchasing above ৳5000+
Cashback ৳80 : For purchasing above ৳4000+
Cashback ৳60 : For purchasing above ৳3000+
Select Language
English
descriptionMedical Overview

Indication

Osteoporosis, Hypoparathyroidism, Rickets, Osteomalacia,Vitamin D Deficiency, Pseudohypoparathyroidism, Familial hypophosphatemia

Administration

May be taken with or without food.

Adult Dose

Oral /IM: Nutritional deficiency Colecalciferol (Vitamin D3) is recommended 5-10 mcg or 1-2ml (200-400 IU)/day Osteoporosis Prophylaxis and tre... View More

Child Dose

Nutritional Supplementation RDA 0-12 months: 400 IU (10 mcg) PO once daily 1-18 years: 600 IU (15 mcg) PO once daily Vitamin D-Resistant Rickets ... View More

Contraindication

Colecalciferol is contraindicated in all diseases associated with hypercalcaemia. It is also contraindicated in patients with known hypersensitivity to ... View More

Mode of Action

Vitamin D3 is a fat-soluble sterol. It is necessary for the regulation and regulation of calcium and phosphate homoeostasis and bone mineralisation. Vit... View More

Precaution

People with the following conditions should exercise caution when considering taking vitamin D supplements: High blood Calcium or Phosphorus level Hea... View More

Side Effect

Generally all nutritional supplements are considered to be safe and well tolerable. However, few side-effects can generally occur including hypercalcaem... View More

Interaction

Increased risk of hypercalcaemia if given with thiazide diuretics, calcium or phosphate. Antiepileptics (e.g. carbamazepine, phenobarbitone, phenytoin &... View More

descriptionDisclaimer

The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More

Open in App